Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3-Reference-Cited by-同舟云学术

Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3

Published:2005-06-10 Issue:4 Volume:100 Page:365-371
ISSN:0300-8428
Container-title:Basic Research in Cardiology
language:en
Short-container-title:Basic Res Cardiol

Author:

Milberg P.,Reinsch N.,Osada N.,Wasmer K.,Mönnig G.,Stypmann J.,Breithardt G.,Haverkamp W.,Eckardt L.

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s00395-005-0533-8.pdf

Reference31 articles.

1. Akar FG, Yan GX, Antzelevitch C, Rosenbaum DS (2002) Unique topographical distribution of M cells underlies reentrant mechanism of torsade de pointes in the long–QT syndrome. Circulation 105:1247–1253

2. Antzelevitch C, Sun ZQ, Zhang ZQ, Yan G (1996) Cellular and ionic mechanisms underling erythromycin–induced long QT intervals and Torsade de Pointes. J Am Coll Cardiol 28:1836–1848

3. Cosio FG, Goicolea A, Lopez GM, Kallmeyer C, Barroso JL (1991) Suppression of Torsades de Pointes with verapamil in patients with atrio–ventricular block. Eur Heart J 12:635–638

4. Dessertenne F (1966) La tachycardie ventriculaire à deux foyers opposés variables. Arch Mal Coeur 59:263–272

5. Dumaine R, Antzelevitch C (2002) Molecular mechanisms underlying the long QT syndrome. Curr Opin Cardiol 17:36–42

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of torsades de pointes: an update;Frontiers in Cardiovascular Medicine;2024-03-05

2. Divergent electrophysiologic action of dapagliflozin and empagliflozin on ventricular and atrial tachyarrhythmias in isolated rabbit hearts;Frontiers in Cardiovascular Medicine;2024-02-22

3. More than 30 years of Brugada syndrome: a critical appraisal of achievements and open issues;Herzschrittmachertherapie + Elektrophysiologie;2023-12-12

4. The new European Society of Cardiology guideline for the management of cardiomyopathies: key messages for cardiac electrophysiologists;Herzschrittmachertherapie + Elektrophysiologie;2023-11-16

5. PDE5 Inhibition Suppresses Ventricular Arrhythmias by Reducing SR Ca 2+ Content;Circulation Research;2021-09-03